Nasentropfen Kinder (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a selective alpha‑adrenergic agonist. When applied to the nasal mucosa it stimulates alpha receptors on vascular smooth muscle, causing vasoconstriction. This reduces blood flow to the nasal tissues, decreasing edema and opening the nasal passages.

The exact dose and frequency are determined by the prescribing healthcare professional based on the child’s age, weight, and severity of symptoms. Caregivers should follow the prescriber’s instructions and the product label carefully.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Use only if the prescriber judges that the benefit outweighs any potential risk. Women who are pregnant or breastfeeding should consult their healthcare provider before using the product.

Enquiries can be submitted on the product page at gnhindia.com by specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasentropfen Kinder uses Xylometazoline, an alpha‑adrenergic agonist, which provides rapid relief of nasal congestion. Compared with older agents like phenylephrine, Xylometazoline often has a longer duration of action and may cause fewer systemic side effects when used as directed.

Store the nasal drops at room temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect it from moisture and direct sunlight, and keep it out of reach of children.

The product is applied as nasal drops. The prescriber will indicate the number of drops per nostril and the frequency. Typically, the child’s head is tilted slightly back, and the prescribed drops are placed into each nostril using the supplied dropper.

Serious risks, though rare, include persistent nasal irritation or ulceration, severe hypertension, and allergic reactions such as rash, swelling of the face or throat, and difficulty breathing. Any of these symptoms require immediate medical attention.

Children with known hypersensitivity to Xylometazoline or any component of the formulation should avoid the product. It is also contraindicated in children with severe hypertension, certain cardiovascular disorders, or when used together with other nasal decongestants without medical supervision.